NM_130810.4:c.271+2657A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_130810.4(DNAAF4):c.271+2657A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 151,636 control chromosomes in the GnomAD database, including 9,738 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 9738 hom., cov: 30)
Exomes 𝑓: 0.25 ( 0 hom. )
Consequence
DNAAF4
NM_130810.4 intron
NM_130810.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00500
Publications
4 publications found
Genes affected
DNAAF4 (HGNC:21493): (dynein axonemal assembly factor 4) This gene encodes a tetratricopeptide repeat domain-containing protein. The encoded protein interacts with estrogen receptors and the heat shock proteins, Hsp70 and Hsp90. An homologous protein in rat has been shown to function in neuronal migration in the developing neocortex. A chromosomal translocation involving this gene is associated with a susceptibility to developmental dyslexia. Mutations in this gene are associated with deficits in reading and spelling. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream cell cycle progression 1 (CCPG1) gene. [provided by RefSeq, Mar 2011]
DNAAF4-CCPG1 (HGNC:43019): (DNAAF4-CCPG1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring dyslexia susceptibility 1 candidate 1 (DYX1C1) and cell cycle progression 1 (CCPG1) genes on chromosome 15. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF4 | NM_130810.4 | c.271+2657A>G | intron_variant | Intron 3 of 9 | ENST00000321149.7 | NP_570722.2 | ||
| DNAAF4 | NM_001033560.2 | c.271+2657A>G | intron_variant | Intron 3 of 8 | NP_001028732.1 | |||
| DNAAF4 | NM_001033559.3 | c.271+2657A>G | intron_variant | Intron 3 of 8 | NP_001028731.1 | |||
| DNAAF4-CCPG1 | NR_037923.1 | n.526+2657A>G | intron_variant | Intron 2 of 15 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.281 AC: 42531AN: 151510Hom.: 9699 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
42531
AN:
151510
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.250 AC: 2AN: 8Hom.: 0 AF XY: 0.333 AC XY: 2AN XY: 6 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
8
Hom.:
AF XY:
AC XY:
2
AN XY:
6
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
1
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.281 AC: 42625AN: 151628Hom.: 9738 Cov.: 30 AF XY: 0.277 AC XY: 20526AN XY: 74118 show subpopulations
GnomAD4 genome
AF:
AC:
42625
AN:
151628
Hom.:
Cov.:
30
AF XY:
AC XY:
20526
AN XY:
74118
show subpopulations
African (AFR)
AF:
AC:
26291
AN:
41272
American (AMR)
AF:
AC:
2492
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
AC:
616
AN:
3468
East Asian (EAS)
AF:
AC:
955
AN:
5138
South Asian (SAS)
AF:
AC:
1206
AN:
4816
European-Finnish (FIN)
AF:
AC:
1278
AN:
10482
Middle Eastern (MID)
AF:
AC:
44
AN:
290
European-Non Finnish (NFE)
AF:
AC:
9178
AN:
67906
Other (OTH)
AF:
AC:
498
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1167
2334
3500
4667
5834
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
857
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.